Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler W Buckner

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 9, 2021
Shortening the Haemophilia Activities List (HAL) from 42 items to 18 itemsIsolde A R Kuijlaars, Janjaap van der Net, Tyler W Buckner, et al.
Expert Review of Hematology|March 17, 2025
A plain language summary on indirectly comparing bleeding after valoctocogene roxaparvovec gene therapy to bleeding with emicizumab prophylaxisJan Astermark, Tyler W Buckner, Laurent Frenzel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2022
Physical therapy within US HTCs: A multicentre survey of utilization, practice patterns and pain management approachesJennifer R Newman, Nancy Durben, Kimberly Baumann, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 4, 2021
Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United StatesConnie H Miller, J Michael Soucie, Vanessa R Byams, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 11, 2024
Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapyRobbin Itzler, Tyler W Buckner, Frank W G Leebeek, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 3, 2012
Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infectionsTyler W Buckner, Cherie Dunphy, Yuri D Fedoriw, et al.
Journal of Racial and Ethnic Health Disparities|May 3, 2023
Racial and Ethnic Differences in Distress, Depression, and Quality of Life in people with hemophiliaStacey A Fedewa, Tyler W Buckner, Sara Guasch Parks, et al.
European Journal of Haematology|September 5, 2018
Reliability and validity of patient-reported outcome instruments in US adults with hemophilia B and caregivers in the B-HERO-S studyTyler W Buckner, Robert Sidonio, Christine Guelcher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2023
Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxisJan Astermark, Tyler W Buckner, Laurent Frenzel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2020
Validation of a new instrument to measure disease-related distress among patients with haemophiliaChristine L Kempton, Mary Michaels Stout, Vaughn Barry, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 9, 2021
Shortening the Haemophilia Activities List (HAL) from 42 items to 18 itemsIsolde A R Kuijlaars, Janjaap van der Net, Tyler W Buckner, et al.
Expert Review of Hematology|March 17, 2025
A plain language summary on indirectly comparing bleeding after valoctocogene roxaparvovec gene therapy to bleeding with emicizumab prophylaxisJan Astermark, Tyler W Buckner, Laurent Frenzel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2022
Physical therapy within US HTCs: A multicentre survey of utilization, practice patterns and pain management approachesJennifer R Newman, Nancy Durben, Kimberly Baumann, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 4, 2021
Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United StatesConnie H Miller, J Michael Soucie, Vanessa R Byams, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 11, 2024
Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapyRobbin Itzler, Tyler W Buckner, Frank W G Leebeek, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 3, 2012
Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infectionsTyler W Buckner, Cherie Dunphy, Yuri D Fedoriw, et al.
Journal of Racial and Ethnic Health Disparities|May 3, 2023
Racial and Ethnic Differences in Distress, Depression, and Quality of Life in people with hemophiliaStacey A Fedewa, Tyler W Buckner, Sara Guasch Parks, et al.
European Journal of Haematology|September 5, 2018
Reliability and validity of patient-reported outcome instruments in US adults with hemophilia B and caregivers in the B-HERO-S studyTyler W Buckner, Robert Sidonio, Christine Guelcher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2023
Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxisJan Astermark, Tyler W Buckner, Laurent Frenzel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2020
Validation of a new instrument to measure disease-related distress among patients with haemophiliaChristine L Kempton, Mary Michaels Stout, Vaughn Barry, et al.
Pageof 5